EP Patent

EP3453761A1 — Oligomer-conjugate complexes and their use

Assigned to Ionis Pharmaceuticals Inc · Expires 2019-03-13 · 7y expired

What this patent protects

Oligonucleotides, chemically-modified oligonucleotides, and oligonucleotide-conjugate complexes for use in research, diagnostics, and/or therapeutics are described herein.

USPTO Abstract

Oligonucleotides, chemically-modified oligonucleotides, and oligonucleotide-conjugate complexes for use in research, diagnostics, and/or therapeutics are described herein.

Drugs covered by this patent

Patent Metadata

Patent number
EP3453761A1
Jurisdiction
EP
Classification
—
Expires
2019-03-13
Drug substance claim
No
Drug product claim
No
Assignee
Ionis Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.